AU2001264769A1 - Induction of apoptosis and cell growth inhibition by protein 4.33 - Google Patents
Induction of apoptosis and cell growth inhibition by protein 4.33Info
- Publication number
- AU2001264769A1 AU2001264769A1 AU2001264769A AU6476901A AU2001264769A1 AU 2001264769 A1 AU2001264769 A1 AU 2001264769A1 AU 2001264769 A AU2001264769 A AU 2001264769A AU 6476901 A AU6476901 A AU 6476901A AU 2001264769 A1 AU2001264769 A1 AU 2001264769A1
- Authority
- AU
- Australia
- Prior art keywords
- apoptosis
- induction
- protein
- cell growth
- growth inhibition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4747—Apoptosis related proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Cell Biology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20494900P | 2000-05-17 | 2000-05-17 | |
US60204949 | 2000-05-17 | ||
PCT/US2001/016437 WO2001087238A2 (en) | 2000-05-17 | 2001-05-17 | Induction of apoptosis and cell growth inhibition by protein 4.33 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001264769A1 true AU2001264769A1 (en) | 2001-11-26 |
Family
ID=22760142
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001264769A Abandoned AU2001264769A1 (en) | 2000-05-17 | 2001-05-17 | Induction of apoptosis and cell growth inhibition by protein 4.33 |
Country Status (5)
Country | Link |
---|---|
US (2) | US7585497B2 (en) |
EP (1) | EP1290162A4 (en) |
AU (1) | AU2001264769A1 (en) |
CA (1) | CA2410056A1 (en) |
WO (1) | WO2001087238A2 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7585497B2 (en) * | 2000-05-17 | 2009-09-08 | Oregon Health & Science University | Induction of apoptosis and cell growth inhibition by protein 4.33 |
WO2002034916A2 (en) | 2000-10-27 | 2002-05-02 | Oregon Health And Science University | Novel mutant igbp-3 molecules that do not bind to igfs, but retain their ability to functionally bind igfbp-3 receptor |
US6887851B2 (en) | 2001-09-18 | 2005-05-03 | Bioexpertise, Llc | IGF-binding protein-derived peptide |
AU2002324672B2 (en) | 2001-09-18 | 2007-11-08 | Bioexpertise, Llc | IGF-binding protein-derived peptide or small molecule |
US6914049B2 (en) | 2001-09-18 | 2005-07-05 | Bioexpertise, Llc | IGF-binding protein-derived peptide or small molecule |
US7465553B2 (en) | 2001-12-31 | 2008-12-16 | Dana-Farber Cancer Institute, Inc. | Psoriasin expression by breast epithelial cells |
WO2005033132A2 (en) | 2003-10-03 | 2005-04-14 | Genentech, Inc. | Igf binding proteins |
WO2008079849A2 (en) * | 2006-12-22 | 2008-07-03 | Genentech, Inc. | Antibodies to insulin-like growth factor receptor |
EP2068276A1 (en) * | 2007-12-04 | 2009-06-10 | Sony Corporation | Information processing device and method, program, and recording medium |
WO2010146059A2 (en) | 2009-06-16 | 2010-12-23 | F. Hoffmann-La Roche Ag | Biomarkers for igf-1r inhibitor therapy |
US20140286966A1 (en) * | 2010-07-06 | 2014-09-25 | Youngman Oh | Methods and compositions for the treatment of metabolic syndrome, obstructive respiratory disorders, cancer and related diseases |
WO2012118796A1 (en) * | 2011-02-28 | 2012-09-07 | The Schepens Eye Research Institute, Inc. | Compositions for controlling neuronal outgrowth |
WO2016193496A1 (en) | 2015-06-04 | 2016-12-08 | Ospedale San Raffaele Srl | Igfbp3 and uses thereof |
NZ738389A (en) | 2015-06-04 | 2019-02-22 | Ospedale San Raffaele Srl | Inhibitor of igfbp3/tmem219 axis and diabetes |
US11179451B2 (en) * | 2016-11-01 | 2021-11-23 | Virginia Commonwealth University | Methods of treating an IGFBP-3R expressing cancer using anti-IGFBP-3R antibodies |
EP3632929A1 (en) * | 2018-10-02 | 2020-04-08 | Ospedale San Raffaele S.r.l. | Antibodies and uses thereof |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4215051A (en) | 1979-08-29 | 1980-07-29 | Standard Oil Company (Indiana) | Formation, purification and recovery of phthalic anhydride |
US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
US4745051A (en) | 1983-05-27 | 1988-05-17 | The Texas A&M University System | Method for producing a recombinant baculovirus expression vector |
US4902505A (en) | 1986-07-30 | 1990-02-20 | Alkermes | Chimeric peptides for neuropeptide delivery through the blood-brain barrier |
US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
US5116742A (en) | 1986-12-03 | 1992-05-26 | University Patents, Inc. | RNA ribozyme restriction endoribonucleases and methods |
US4987071A (en) | 1986-12-03 | 1991-01-22 | University Patents, Inc. | RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods |
US4904582A (en) | 1987-06-11 | 1990-02-27 | Synthetic Genetics | Novel amphiphilic nucleic acid conjugates |
EP0378576B1 (en) | 1987-09-11 | 1995-01-18 | Whitehead Institute For Biomedical Research | Transduced fibroblasts and uses therefor |
US5399346A (en) | 1989-06-14 | 1995-03-21 | The United States Of America As Represented By The Department Of Health And Human Services | Gene therapy |
US5399349A (en) | 1992-02-06 | 1995-03-21 | Paunescu; Calin | Treatment of acne |
WO1997009998A2 (en) * | 1995-09-14 | 1997-03-20 | Bristol-Myers Squibb Company | Insulin-like growth factor binding protein 3 (igf-bp3) in treatment of p53-related tumors |
US6534631B1 (en) * | 1998-07-15 | 2003-03-18 | Human Genome Sciences, Inc. | Secreted protein HT5GJ57 |
US7368531B2 (en) * | 1997-03-07 | 2008-05-06 | Human Genome Sciences, Inc. | Human secreted proteins |
US7411051B2 (en) * | 1997-03-07 | 2008-08-12 | Human Genome Sciences, Inc. | Antibodies to HDPPA04 polypeptide |
DE19818619A1 (en) * | 1998-04-21 | 1999-10-28 | Metagen Gesellschaft Fuer Genomforschung Mbh | New nucleic acid sequences expressed in bladder tumor tissue, and derived polypeptides, for treatment of bladder tumor and identification of therapeutic agents |
CA2329072A1 (en) * | 1998-05-29 | 1999-12-02 | Incyte Pharmaceuticals, Inc. | Human transmembrane proteins |
US7368527B2 (en) * | 1999-03-12 | 2008-05-06 | Human Genome Sciences, Inc. | HADDE71 polypeptides |
US7585497B2 (en) * | 2000-05-17 | 2009-09-08 | Oregon Health & Science University | Induction of apoptosis and cell growth inhibition by protein 4.33 |
-
2001
- 2001-05-17 US US10/276,491 patent/US7585497B2/en not_active Expired - Fee Related
- 2001-05-17 EP EP01939229A patent/EP1290162A4/en not_active Withdrawn
- 2001-05-17 CA CA002410056A patent/CA2410056A1/en not_active Abandoned
- 2001-05-17 WO PCT/US2001/016437 patent/WO2001087238A2/en active Application Filing
- 2001-05-17 AU AU2001264769A patent/AU2001264769A1/en not_active Abandoned
-
2009
- 2009-06-04 US US12/478,599 patent/US20100120143A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2001087238A3 (en) | 2002-06-06 |
EP1290162A4 (en) | 2005-08-17 |
CA2410056A1 (en) | 2001-11-22 |
US20100120143A1 (en) | 2010-05-13 |
US20040072285A1 (en) | 2004-04-15 |
US7585497B2 (en) | 2009-09-08 |
WO2001087238A2 (en) | 2001-11-22 |
EP1290162A2 (en) | 2003-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001229712A1 (en) | Reduction of hair growth | |
AU2002214629A1 (en) | Non-metallic bioreactor and uses | |
AU7620200A (en) | Compositions and methods relating to the inhibition of casomorphin and gluteomorphin | |
AU2001264769A1 (en) | Induction of apoptosis and cell growth inhibition by protein 4.33 | |
AUPR030900A0 (en) | Growth factor complex | |
AUPP303498A0 (en) | Inhibition of gram positive bacteria | |
AU6229699A (en) | Beta-amyloid formation inhibitors | |
AU1488501A (en) | Methods of inhibiting metastasis | |
AU2002216223A1 (en) | Preservation of cells | |
AU2003228450A1 (en) | Inhibition of tumor growth via peroxiredoxin 3 | |
AU2591299A (en) | Human protein kinase c inhibitor | |
AU2002222471A1 (en) | Inhibitory agents derived from specific growth factors | |
AU4774200A (en) | Long term cell culture of human carcinoma | |
AU2002342355A1 (en) | Identifying and controlling the growth of estrogen-responsive cells | |
AU2001274080A1 (en) | Regulation of human transketolase-like enzyme | |
AU2001281048A1 (en) | Floral induction gene | |
AU2001281939A1 (en) | Regulation of human alpha-hydroxysteroid dehydrogenase-like enzyme | |
AU2001285782A1 (en) | Regulation of human phosphodiesterase-like enzyme | |
AU2002210525A1 (en) | Regulation of human phospholipase-like enzyme | |
AU2002215942A1 (en) | Regulation of human carboxylesterase-like enzyme | |
AU2001281969A1 (en) | Regulation of human carboxylesterase-like enzyme | |
AU2002230889A1 (en) | Target enzymes | |
AU3376501A (en) | Improvement of implantation rate | |
AU5033101A (en) | Regulation of human heparanase-like enzyme | |
AU5647101A (en) | Over expression of the whn protein |